Vicore Pharma Holding AB (publ) (VCRE)
NASDAQ: VCRE · Real-Time Price · USD
11.28
+0.22 (1.99%)
At close: Jul 28, 2026, 4:00 PM EDT
11.45
+0.17 (1.51%)
After-hours: Jul 28, 2026, 4:10 PM EDT

Vicore Pharma Holding AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-484.69-452.39-194.19-321.51-290.73-294.82
Depreciation & Amortization
-02.243.42-3.6
Stock-Based Compensation
-14.058.077-3.86
Other Adjustments
36.939.230.94144.2911.75-2.79
Change in Receivables
-5.63-3.08-35.6-4.28-1.6-0.34
Changes in Accrued Expenses
46.2343.8933.77-6.36-19.3427.41
Changes in Income Taxes Payable
-0.09-----
Operating Cash Flow
-407.27-375.74-164.95-249.58-299.92-265.17
Operating Cash Flow Growth
------
Purchases of Intangible Assets
-----30
Purchases of Investments
-948.16-983.95-64.81-199.040-77
Proceeds from Sale of Investments
591.43383.45213.8554.587770
Investing Cash Flow
-355.32-600.51149.04-144.4674-7
Long-Term Debt Repaid
----0.06-0.25-0.24
Net Long-Term Debt Issued (Repaid)
----0.06-0.25-0.24
Issuance of Common Stock
455.1455.1882.14500.41200336
Net Common Stock Issued (Repurchased)
455.1455.1882.14500.41200336
Other Financing Activities
-24.55-24.55-48.08-29.49-12.71-17.58
Financing Cash Flow
430.54430.54834.06470.86187.04318.18
Foreign Exchange Rate Adjustments
-6.01-32.164.2301.48-0.43
Net Cash Flow
-332.04-545.7818.1676.82-38.8846.01
Free Cash Flow
-407.27-375.74-164.95-249.58-299.92-265.17
Free Cash Flow Growth
------
FCF Margin
-11547.10%-9843.78%-150.85%---
Free Cash Flow Per Share
-1.62-1.57-1.21-2.58-4.15-3.81
Levered Free Cash Flow
-428.41-433.58-132.63-313.94-308.02-265.71
Unlevered Free Cash Flow
-438.63-408.5-157.89-324.05-309.68-263.55